June 07, 2023

Federal Legislative Opportunities for Improved Cannabis Regulation

FDLI’s Legal and Practical Issues in Cannabis Regulation Conference



Libby Baney is moderating a panel on “Federal Legislative Opportunities for Improved Cannabis Regulation” for the Food and Drug Law Institute. The panel includes Thomas Berry, senior VP of regulatory compliance at Greenleaf Health; Andrew Freedman, senior VP of Forbes Tate Partners and executive director at Coalition for Cannabis Policy, Education, and Regulation; and Jensen Jose, regulatory counsel at the Center for Science in the Public Interest.

Congress is deliberating the provisions of the 2023 Farm Bill, cannabis-specific legislation has been introduced in the House of Representatives, and the FDA has requested additional legislation to create a new pathway to market for cannabidiol (CBD) products. This session addresses: opportunities under the Farm Bill to strengthen federal cannabis regulation; cannabis-related bills currently before Congress and their likelihood of success; and what additional legislation is needed for a well-regulated adult-use cannabis market.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.